dsip jhu The 2025 Diversity Summer Internship Program (DSIP) application at Johns Hopkins Bloomberg School of Public Health is open now through February 1, 2025. If you have completed two years of college and 771ada63-31eb-4a7c-b507-ba666a602eab.png

This is a custom-compounded injectable formulation combining two active ingredients: Semaglutide a GLP-1 receptor agonist known for appetite suppression, improved glucose control, and weight loss effects Empower Pharmacy+1 Cyanocobalamin a version of vitamin B12, important for energy metabolism, neurological function, and red blood cell production Empower Pharmacy+2Wikipedia+2 Empower Pharmacy produces this injectable under their compounding operations and offers it through their 503A compounding pharmacy (patient-specific prescriptions) and 503B facility for larger sterile compounding needs Empower Pharmacy+3Empower Pharmacy+3Empower Pharmacy+3 Because its a compounded product, it is not FDA-approved as a branded drug

requires screening and monitoring Tirzepatide (GLP-1/GIP medication) What it is: Prescription GLP-1/GIP medication Primary effect: Appetite regulation and satiety Evidence for weight loss: Strong What to know: FDA-approved options exist for chronic weight management

The precursor literature includes human pharmacokinetic work

Chemerin levels as predictor of acute coronary events: A case-control study nested within the veterans affairs normative aging study

Getting this dialed in can be the difference between feeling great on TRT a